Palo Alto, Calif.-based blood testing startup Theranos welcomed Silicon Valley executive Daniel Warmenhoven to its board of directors to take the place of Riley Bechtel, chairman of the construction company Bechtel Corp., the startup announced Thursday.
Mr. Bechtel is retiring from his directorship due to health issues. Mr. Warmenhoven, who will step in immediately, previously served as CEO and executive chairman of the board for NetApp, a Fortune 500 data storage and management firm.
"Mr. Warmenhoven has deep experience in building great companies," Theranos CEO Elizabeth Holmes said in a statement. "His insights will be extremely useful as we now work to commercialize our miniLab and proprietary software systems."
The company also plans to dissolve its board of counselors on Jan. 1 to consolidate and streamline its advisory structure. Theranos' board of directors and a scientific and medical advisory board will remain intact.
More articles on leadership and management:
Ascension CEO to meet with Trump transition team
DeKalb Medical lays off about 60 employees, CEO resigns
Idaho-based St. Luke's Health System names 3 new board members